Trial Profile
Clinical Trials Insight: 700012652
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Jun 2009
Price :
$35
*
At a glance
- Drugs Elagolix (Primary)
- Indications Endometriosis; Pelvic pain
- Focus Therapeutic Use
- Sponsors Neurocrine Biosciences
- 15 Mar 2006 New trial record.